Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem

Antimicrob Agents Chemother. 2003 Feb;47(2):755-8. doi: 10.1128/AAC.47.2.755-758.2003.

Abstract

A Klebsiella pneumoniae isolate was identified that had reduced susceptibility to several expanded-spectrum cephalosporins and imipenem. That isolate produced a chromosome-encoded SHV-type beta-lactamase, SHV-38, that had an alanine to valine substitution in position Ambler 146 compared to beta-lactamase SHV-1. The kinetic parameters for purified beta-lactamases SHV-38 and SHV-1 showed that the hydrolytic spectrum of SHV-38 included only ceftazidime and imipenem. This report is the first example of an SHV-type beta-lactamase capable of hydrolyzing imipenem.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / antagonists & inhibitors
  • Anti-Bacterial Agents / pharmacology*
  • Humans
  • Imipenem / antagonists & inhibitors
  • Imipenem / pharmacology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics*
  • Klebsiella pneumoniae / isolation & purification
  • Male
  • Middle Aged
  • beta-Lactamases / genetics*
  • beta-Lactamases / isolation & purification
  • beta-Lactamases / pharmacology

Substances

  • Anti-Bacterial Agents
  • Imipenem
  • beta-lactamase PIT-2
  • beta-Lactamases